FAQ

N,N-diethyltryptamine oxalate (1:1)

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1959-2013
0119592013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Simultaneous determination of tryptamine analogues in designer drugs using gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
In recent years, a large number of tryptamine-based designer drugs have been encountered in forensic samples. We have developed… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2002
2002
5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.
The role of 5-HT2A-mediated stimulation of phosphoinositide hydrolysis in the discriminative effects of hallucinogens was… (More)
Is this relevant?
1989
1989
Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe.
Mycelial cultures of Psilocybe cubensis capable of forming psilocybin and psilocin de novo display a high capacity for… (More)
Is this relevant?
1983
1983
The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
 
Is this relevant?
1959
1959
Observations on the psychotogenic effect of N-N diethyltryptamine, a new tryptamine derivative.
SINCE Evarts, Fabing and Marrazzi reported on bufotenine and Szára on N-N dimethyltryptamine (DMT) the tryptamine derivatives… (More)
  • figure I
  • figure 2
Is this relevant?